Weight management
Weight-loss tablets or injections: what is the difference?
Compare how weight-management tablets and injections are used, with the questions that can help a clinician select a suitable option.
- Written by
- MedsHut clinical team
- Pharmacy content team
- Published
- Updated 2 September 2026
Weight-management medicines can be tablets, capsules, or injections. The format is only one part of the decision. Different medicines work in different ways and have different instructions, side effects, and eligibility criteria.
A clinician must assess you before they prescribe a prescription-only weight-management medicine.
How do the medicines work?
Some medicines act on signals that control appetite and fullness. Semaglutide acts on the GLP-1 system. Tirzepatide acts on the GLP-1 and GIP systems. These medicines can reduce appetite and help a person feel full for longer.
Orlistat works in a different way. It reduces how much fat the body absorbs from food.
The format does not tell you how the medicine works. For example, semaglutide can have different authorised forms and uses. Always check the exact medicine, indication, and instructions.
How often do you take them?
Instructions differ by medicine:
- tirzepatide for weight management is a weekly injection
- injectable semaglutide for weight management is usually used once each week
- the semaglutide weight-management tablet approved in June 2026 is taken once each day
- orlistat capsules are taken with meals that contain fat, according to the supplied instructions
Do not change the dose or switch products without advice from a healthcare professional.
Is a tablet more convenient?
A tablet avoids an injection, but it can have detailed timing and food instructions. A daily medicine also needs a daily routine. An injection needs correct storage, preparation, and injection technique, but some products are used only once each week.
Think about what you can use correctly and consistently. Tell the clinician if you:
- work shifts or have irregular meal times
- travel often
- have difficulty swallowing tablets
- have concerns about needles
- cannot store a medicine as instructed
- use other medicines at specific times
The clinician can use this information during the assessment.
Are the side effects different?
Side effects depend on the active medicine, not only on whether it is a tablet or injection.
GLP-1 and related medicines commonly cause digestive side effects, such as nausea, vomiting, diarrhoea, constipation, and stomach pain. An injection can also cause irritation at the injection site.
Orlistat commonly causes bowel side effects because of the way that it reduces fat absorption. These can include oily stools, wind, and an urgent need to open the bowels.
Some serious side effects need urgent medical advice. Read the leaflet supplied with the medicine and follow the instructions from your prescriber. Call NHS 111 if you think that you have a serious side effect. Call 999 for a medical emergency.
Does one option cause more weight loss?
Do not select treatment from a headline percentage. Results from separate clinical trials cannot always be compared directly. Trial populations, treatment periods, lifestyle support, and methods can differ.
Your result can also differ from an average trial result. A prescriber will consider expected benefits, risks, side effects, other health conditions, and whether you can use the medicine correctly.
All NICE-recommended weight-management medicines are used with a reduced-calorie diet and increased physical activity.
What should you discuss with a clinician?
Tell the clinician about:
- all prescribed and non-prescribed medicines that you use
- diabetes, pancreas, gallbladder, kidney, liver, or digestive conditions
- previous weight-management treatments
- pregnancy, plans for pregnancy, breastfeeding, and contraception
- previous side effects or allergic reactions
- your eating patterns and treatment goals
Do not use medicine that was prescribed for another person. Do not buy prescription medicine from a seller that does not complete a proper consultation.
A useful way to compare options
Ask these five questions:
- Is this medicine authorised and suitable for my health needs?
- How and when must I take it?
- What side effects need routine or urgent advice?
- How will we measure whether it helps me?
- What support will I have for food, activity, and long-term weight management?
The best format is the one that is clinically suitable and that you can use safely as part of a wider plan.
Sources
- NHS: Overweight and obesity
- NICE: Medicine options for weight management in adults
- NHS: Tirzepatide
- NHS: Orlistat
- MHRA: First GLP-1 tablet for weight loss approved in the UK
Sources accessed on 2 September 2026. Regulatory status and availability can change.